Search

Author/Creator Major, Christopher

1. Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib. (3rd May 2021)

Authors:
Balasubramanian, Sriram; Wang, Songbai; Major, Christopher; Hodkinson, Brendan; Schaffer, Michael; Sehn, Laurie H.; Johnson, Peter; Zinzani, Pier Luigi; Carey, Jodi; Shreeve, S. Martin; Sun, Steven; Gerecitano, John; Vermeulen, Jessica; Staudt, Louis M.; Wilson, Wyndham
Journal:
British journal of haematology
Issue:
Volume 194:Number 1(2021)
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment. (18th April 2020)

Authors:
Wang, Songbai; Burgess, Mike; Major, Christopher; English, Alistair; Sweeney, Maranna; Hartmann, Arndt
Journal:
Journal of pathology
Issue:
Volume 6:Number 3(2020)
Page Start:
207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search